<?xml version="1.0" ?>
<GlossaryTerm id="CDR0000513076">
  <TermName>Naropin</TermName>
  <TermPronunciation>(NUH-roh-pin)</TermPronunciation>
  <TermDefinition>
    <DefinitionText>A drug used to control pain and to cause a temporary loss of feeling in one part of the body, during and after surgery. It is also being studied for pain control after cancer surgery. It is a type of local anesthetic. Also called ropivacaine hydrochloride.</DefinitionText>
    <Dictionary>Cancer.gov</Dictionary>
    <Audience>Patient</Audience>
  </TermDefinition>
  <MediaLink ref="CDR0000718121" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;Naropin&quot;" language="en" id="_3"/>
  <MediaLink ref="CDR0000718120" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;Naropin&quot;" language="es" id="_4"/>
  <SpanishTermName>Naropin</SpanishTermName>
  <SpanishTermDefinition>
    <DefinitionText>Medicamento usado para controlar el dolor y causar una pérdida temporal de sensibilidad en una parte del cuerpo, durante y después de la cirugía. Asimismo, está en estudio para el control del dolor después de la cirugía del cáncer. Es un tipo de anestésico local. También se llama clorhidrato de ropivacaína.</DefinitionText>
    <Dictionary>Cancer.gov</Dictionary>
    <Audience>Patient</Audience>
  </SpanishTermDefinition>
  <DateFirstPublished>2006-10-21</DateFirstPublished>
  <DateLastModified>2007-06-19</DateLastModified>
</GlossaryTerm>
